Liens utiles

Institut National du Cancer agence d'expertise sanitaire et scientifique en cancérologie

Nota Bene Cancer bulletin de veille bibliographique dans les divers domaines de la recherche sur les cancers

Onco Actu brèves sur le web anglophone

 

Tous les liens utiles

Accueil » La R&D d'Unicancer » Les publications de la R&D d'Unicancer » Les publications

Publications de la R&D d'Unicancer

2015

Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial.

Gravis G et al., Eur Urol. 2015 Nov 21. pii: S0302-2838(15)01103-3. doi: 10.1016/j.eururo.2015.11.005.

2015

Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer.

Ladoire S et al., Autophagy. 2015 Oct 3;11(10):1878-90. doi: 10.1080/15548627.2015.1082022.

2015

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.

Forbes JF,. Lancet. 2015 Dec 11. pii: S0140-6736(15)01129-0. doi: 10.1016/S0140-6736(15)01129-0.

2015

Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial.

Guiu S et al., Future Oncol. 2015;11(16):2283-97. doi: 10.2217/fon.15.102.

2015

UNICANCER-PEGASE 07 study: a randomized phase III trial evaluating postoperative docetaxel-5FU regimen after neoadjuvant dose-intense chemotherapy for treatment of inflammatory breast cancer.

Gonçalves A et al. Ann Oncol. 2015 Aug;26(8):1692-7. doi: 10.1093/annonc/mdv216. Epub 2015 May 5

2014

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).

Lancet Oncol. 2014 Mar;15(3):267-74

2014

Radiation plus docetaxel and cisplatin in locally advanced pancreatic carcinoma: a non-comparative randomized phase II trial

Dig Liver Dis. 2014 Oct;46(10):950-5

2014

Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial.

Lancet Oncol. 2014 Mar;15(3):305-14.

2014

Results in the elderly with locally advanced rectal cancer from the ACCOR12/PRODIGE 2 phase III trial: tolerance and efficacy.

Radiother Oncol. 2014 Jan;110(1):144-9

2014

Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.

Lancet Oncol. 2014 Dec;15(13):1442-50)